Development of low-cost devices for image-guided photodynamic therapy treatment of oral cancer in global health settings

Author(s):  
Hui Liu ◽  
Grant Rudd ◽  
Liam Daly ◽  
Joshua Hempstead ◽  
Yiran Liu ◽  
...  
2015 ◽  
Vol 5 (1) ◽  
Author(s):  
Joshua Hempstead ◽  
Dustin P. Jones ◽  
Abdelali Ziouche ◽  
Gwendolyn M. Cramer ◽  
Imran Rizvi ◽  
...  

2015 ◽  
Vol 12 (3) ◽  
pp. 328-329
Author(s):  
Qin Feng Ng ◽  
Ramaswamy Bhuvaneswari ◽  
Patricia S.P. Thong ◽  
Khee Chee Soo

2019 ◽  
Vol 9 (1) ◽  
Author(s):  
Srivalleesha Mallidi ◽  
Amjad P. Khan ◽  
Hui Liu ◽  
Liam Daly ◽  
Grant Rudd ◽  
...  

Abstract Oral cancer prevalence is increasing at an alarming rate worldwide, especially in developing countries which lack the medical infrastructure to manage it. For example, the oral cancer burden in India has been identified as a public health crisis. The high expense and logistical barriers to obtaining treatment with surgery, radiotherapy and chemotherapy often result in progression to unmanageable late stage disease with high morbidity. Even when curative, these approaches can be cosmetically and functionally disfiguring with extensive side effects. An alternate effective therapy for oral cancer is a light based spatially-targeted cytotoxic therapy called photodynamic therapy (PDT). Despite excellent healing of the oral mucosa in PDT, a lack of robust enabling technology for intraoral light delivery has limited its broader implementation. Leveraging advances in 3D printing, we have developed an intraoral light delivery system consisting of modular 3D printed light applicators with pre-calibrated dosimetry and mouth props that can be utilized to perform PDT in conscious subjects without the need of extensive infrastructure or manual positioning of an optical fiber. To evaluate the stability of the light applicators, we utilized an endoscope in lieu of the optical fiber to monitor motion in the fiducial markers. Here we showcase the stability (less than 2 mm deviation in both horizontal and vertical axis) and ergonomics of our applicators in delivering light precisely to the target location in ten healthy volunteers. We also demonstrate in five subjects with T1N0M0 oral lesions that our applicators coupled with a low-cost fiber coupled LED-based light source served as a complete platform for intraoral light delivery achieving complete tumor response with no residual disease at initial histopathology follow up in these patients. Overall, our approach potentiates PDT as a viable therapeutic option for early stage oral lesions that can be delivered in low resource settings.


Head & Neck ◽  
2018 ◽  
Vol 41 (4) ◽  
pp. 1032-1038 ◽  
Author(s):  
Yuxin Wang ◽  
Diya Xie ◽  
Ziyang Wang ◽  
Xudong Zhang ◽  
Qian Zhang ◽  
...  

Oncotarget ◽  
2019 ◽  
Vol 10 (58) ◽  
pp. 6079-6095 ◽  
Author(s):  
Channay Naidoo ◽  
Cherie Ann Kruger ◽  
Heidi Abrahamse

2020 ◽  
Vol 10 (1) ◽  
pp. 112
Author(s):  
Brenda Yuliana Herrera-Serna ◽  
Edith Lara-Carrillo ◽  
Victor Hugo Toral-Rizo ◽  
Regiane Cristina do Amaral ◽  
Raul Alberto Aguilera-Eguía

2021 ◽  
pp. 1-3
Author(s):  
Nicholas Clute-Reinig ◽  
Suman Jayadev ◽  
Kristoffer Rhoads ◽  
Anne-Laure Le Ny

Dementia and Alzheimer’s disease (AD) are global health crises, with most affected individuals living in low- or middle-income countries. While research into diagnostics and therapeutics remains focused exclusively on high-income populations, recent technological breakthroughs suggest that low-cost AD diagnostics may soon be possible. However, as this disease shifts onto those with the least financial and structural ability to shoulder its burden, it is incumbent on high-income countries to develop accessible AD healthcare. We argue that there is a scientific and ethical mandate to develop low-cost diagnostics that will not only benefit patients in low-and middle-income countries but the AD field as a whole.


Sign in / Sign up

Export Citation Format

Share Document